Bioauxilium specializes in the design, development and manufacturing of ready-to-use TR-FRET assay kits that simplify laboratory workflow and accelerate drug discovery and life sciences research.
At the SLAS2022 International Conference and Exhibition in Boston, we announced the expansion of our no-wash THUNDER™ time-resolved Förster resonance energy transfer (TR-FRET) technology portfolio by introducing new cell signaling pathway and biomarker research assay kits, along with a panel of “mix and match” toolbox reagents. The new offerings bring our portfolio to a total of […]
See moreBioAuxilium has published an article in the J Vis Exp (JoVE) Journal (Biochemistry). In this paper, we describe in detail protocols for the simple, sensitive, robust, and cost-effective measurement in a 384-well format of endogenous phosphorylated STAT1/3/4/5/6 proteins, together with total STAT1/3/5/6, in cell lysates using the THUNDER™ TR-FRET platform. In brief: We measured the […]
See moreBioauxilium has initiated strategic collaborations with leading developers of microplate detection instruments to demonstrate the compatibility of its increasingly popular THUNDER™ TR-FRET assay platform with select high-value multimode microplate readers under real assay conditions. Agilent BioTek® has recently evaluated the performance of the THUNDER™ Phospho-AKT pan (S473) TR-FRET Cell Signaling Assay Kit on the Synergy™ […]
See more
Bioauxilium is proud to announce the publication of an updated Application Note describing for the first time a comparison among three commercial TR-FRET assay platforms for measuring endogenous phosphoproteins in cellular lysates. The results of this head-to-head study demonstrate superior or comparable performance of THUNDER™ Cell Signaling Assays Kits to that of two existing TR‑FRET […]
See more